Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial.
F Tomao, S Tomao - Journal of Clinical Oncology: Official Journal …, 2014 - europepmc.org
F Tomao, S Tomao
Journal of Clinical Oncology: Official Journal of the American Society …, 2014•europepmc.orgA comment on this article appears in" Reply to F. Tomao et al." J Clin Oncol. 2014 Nov 1; 32
(31): 3580. This is a comment on" Bevacizumab combined with chemotherapy for platinum-
resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial." J
Clin Oncol. 2014 May 1; 32 (13): 1302-8.
(31): 3580. This is a comment on" Bevacizumab combined with chemotherapy for platinum-
resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial." J
Clin Oncol. 2014 May 1; 32 (13): 1302-8.
A comment on this article appears in" Reply to F. Tomao et al." J Clin Oncol. 2014 Nov 1; 32 (31): 3580. This is a comment on" Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial." J Clin Oncol. 2014 May 1; 32 (13): 1302-8.
europepmc.org